| |
Untreated (n = 50)
|
ART-Treated (n = 49)
|
P value
|
|---|
|
Age, years
|
41 (33–46)
|
43 (36–48)
|
0.249
|
|
Sex
|
90% (45) Male
|
88% (43) Male
|
0.722
|
|
Etnicity
|
90% (45) Caucasian
|
86% (42) Caucasian
|
0.514
|
|
Transmission of HIV
|
82% (41) MSM
|
74% (36) MSM
|
0.618
|
|
Current smoker
|
42% (21)
|
41% (20)
|
0.869
|
|
HIV-RNA, (copies/mL)
|
23,026 (5517–90,321)
|
19 (19–20)
|
< 0.001
|
|
Current CD4+ T-cell count, (cells/μL)
|
560 (415–795)
|
610 (480–875)
|
0.363
|
|
Duration of HIVa (months)
|
28 (8–75)
|
73 (36–151)
|
0.009
|
- Summary of clinical and demographic characteristics of the study population previously published in [31]. from Continuous data are presented as medians and (interquartile ranges) and categorical data as percentages and (total numbers). Untreated and treated individuals were compared by Mann-Whitney U test
-
aDuration since 1st positive HIV-1 test
-
cART antiretroviral therapy, MSM Men who have sex with men
